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Errata
Color figures for Pimental JL, Martinez-Maldonado M,
Wilcox JN, Wang 5, and Luo C: Regulation of renin-angioten-
sin system in unilateral ureteral obstruction (Kidney mt 44:
390—400) were sponsored by Marion Merrell Dow, Inc.
The following table was intended to appear in Nissenson AR,
Prichard SS, Cheng IKP, Gokal R, Kubota M, Majorca R,
Riella MC, Rottembourg J, and Stewart JH: Non-medical
factors that impact on ESRD modality selection (Kidney mt
S40: Sl20—S127). The editor regrets the error.
Appendix 1: Physician and Facility Reimbursement for ESRD Treatment*
Country
Hemodialysis Peritoneal Dialysis Modality Utilization
Physician Facility HD CPDPhysician Facility
Australia S G S 0 69 31
Austria 5 G S I 93 7
Brazil (Public)
(Private)
756
756
8900
8900
264
660
13450
13450
79 21
Canada 3806—12558 G 1177—2434 G 63 37
China S 7840 S 4900 86 14
Denmark S G S G 63 37
Finland S R S 41700 52 48
France (Hospital)
(Clinic)
(Auto)
(Home)
S
7020
P
S
G
46332
26364
29484
S
No Fee
No Fee
S
0
None
None
26208
87
100
100
87
13
0
0
13
Germany (Hospital)
(Kuratorium)
(Private)
S
S
3640
G
30160
23636
S
5
1134
G
22060
22060
93.6
87
98.4
6.4
13
1.6
Hong Kong N.A. Self Pay N.A. Self Pay 32 68
Iceland S G S G 68 32
Indonesia N.A. 6800 N.A. 6800 94 6
Italy (Public)
(Private)
S
P
G
N.A.
5
No Fee
0
None
85
100
15.5
0
Japan 11572 42548 5930 37942 94 6
Korea P 9700 657 13160 70 30
Malaysia N.A. 4800 N.A. 4200 93 7
Mexico S G S G 9 91
New Zealand S G S G 50 50
Norway S G S G 74 26
1204 International Society of Nephrology
Appendix 1: Continued
Country
Hemodialysis Peritoneal Dialysis Modality Utilization
Physician Facility HD CPDPhysician Facility
Philippines S Self Pay S Self Pay 75 25
Singapore NA. 2600 N.A. 2600 77 23
Spain (Hospital) S G S G 83.5 16.5
(Auto) P 14664 No Fee 14560 100 0
(Home) S 16692 S 14560 85.5 14.5
Sweden S R S 28000 63 37
Switzerland S 47000 S 30000 80 20
Taiwan 9660 23100 288 17100 95 5
Thailand N.A. 10000 N.A. 8000 45 55
United Kingdom S G S 0 49 51
United States 1584—2438 20280 1584—2636 20280 83 17
Venezuela (Public) S 15792+ S 18300 50 50
(Private) 3230 15792+ No Fee 18300 83 17
* All numbers are in U.S. dollars/yr/pt:
For physician reimbursement: S = salaried; P = physician gets total reimbursement minus the cost of goods and services;
For facility reimbursement: (3 = public funding, usually by a global mechanism for a facility or region (see text); R = reimbursement is at
cost plus 5%; I = private insurance payments on an individual patient basis; Self-pay = individual patient or non-governmental charity
pays the cost of treatment.
N.A. = Not available
